Explore Glow Blend, BPC-157, TB-500, PT-141, Tesamorelin, and NAD+ therapy
Una revisin (Pollard & Pomfrett, 2001) lo calific como "increblemente seguro", sealando que ninguna dosis probada de DSIP result letal en animales y que no se han reportado efectos adversos significativos, aparte de ocasionales cefaleas, nuseas o vrtigo leves y transitorios en humanos
If the Real Issue Is: Gut Symptoms, Inflammation, or Body Changes Besides joint and muscle pain and injury, another popular claim about the BPC-157 peptide is that it helps with gut healing
Better measurement precision at a larger amount is not an argument for using a larger amount under a non-monotonic dose-response, a precisely measured wrong dose is still a wrong dose
References Gwyer D, Wragg NM, Wilson SL